SCHEMBL3836747

SCHEMBL3836747

Fc1ccc2ccccc2c1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
HSD17B10 Q99714 4/20 0.55
CYP2A6 P11509 3/20 0.55
TSHR P16473 3/20 0.55
TDP1 Q9NUW8 1/20 0.55
HPRT1 P00492 2/20 0.52
PTPN22 Q9Y2R2 1/20 0.46
HIF1A Q16665 1/20 0.46
CYP1B1 Q16678 1/20 0.46
CYP1A2 P05177 3/20 0.41
PAX8 Q06710 1/20 0.41
NPC1 O15118 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
HPGD P15428 2/20 0.40
MEN1 O00255 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
THRB P10828 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30366237 1.00 ALDH1A1 (0.55) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL29930545 1.00 ALDH1A1 (0.55) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL30257704 0.88 HPRT1 (0.64) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL26190035 0.88 HPRT1 (0.64) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL27990175 0.84 HPRT1 (0.40) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL26190016 0.83 HSD17B10 (0.48) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL30584056 0.81 HPRT1 (0.36) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL31589324 0.81 ALDH1A1 (0.58) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL590476 0.80 PTPN22 (0.60) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL6838128 0.78 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP2A6TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203541-B1 ORGANIC SEMICONDUCTOR COMPOSITION FUJIFILM CORP (JP) 2022-07-06 EP claimed
US-10793584-B2 Naphthobischalcogenadiazole derivative and production method therefor OSAKA UNIVERSITY (JP) 2020-10-06 US claimed
US-20190337966-A1 NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR OSAKA UNIVERSITY (JP) 2019-11-07 US claimed
EP-3564245-A1 NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR Osaka University (JP) 2019-11-06 EP claimed
EP-3203541-A1 ORGANIC SEMICONDUCTOR COMPOSITION AND ORGANIC SEMICONDUCTOR ELEMENT Fujifilm Corporation (JP) 2017-08-09 EP claimed
US-20170125694-A1 ORGANIC SEMICONDUCTOR COMPOSITION AND ORGANIC SEMICONDUCTOR ELEMENT FUJIFILM CORPORATION (JP) 2017-05-04 US claimed
CN-102031121-B Liquid crystal composition and liquid crystal display device using the same CHIMEI INNOLUX CORP 2014-11-26 CN claimed
US-6129958-A NON RACEMIC TILTED SEMATIC LIQUID CRYSTAL MIXTURE SHOWS A HIGH SWITCHING SPEED WHEN DRIVEN AT A LOW VOLTAGE HOECHST REASEARCH & TECHNOLOGY DEUTSCHLAND GMBH & CO. KG (DE) 2000-10-10 US claimed
EP-0916712-A1 Chiral smectic liquid crystal mixture containing 1,2-difluoronaphthalenes Aventis Research & Technologies GmbH & Co. KG (DE) 1999-05-19 EP claimed
EP-0915146-A1 Chiral smectic liquid crystal mixture containing 1, 2-Difluoronaphthalenes Aventis Research & Technologies GmbH & Co. KG (DE) 1999-05-12 EP claimed
EP-3527600-B1 ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER ASAHI CHEMICAL IND (JP) 2025-07-09 EP disclosed
US-20240004296-A1 RESIST UNDERLAYER FILM-FORMING COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2024-01-04 US disclosed
CN-116419937-A Composition for forming resist underlayer film 日产化学株式会社 2023-07-11 CN disclosed
CN-115991815-A Halogenated modified prepared photoresist resin material and preparation method thereof 中国科学院长春应用化学研究所 2023-04-21 CN disclosed
US-20230114799-A1 ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-04-13 US disclosed
US-5512567-A KAPPA-RECEPTOR AGONISTS SANKYO COMPANY, LIMITED (JP) 1996-04-30 US disclosed
US-5270327-A Piperidine derivatives SANKYO COMPANY, LIMITED (JP) 1993-12-14 US disclosed
EP-0356247-B1 ANALGESIC CARBOXYLIC ACID AMIDE DERIVATIVES Sankyo Company Limited (JP) 1993-03-17 EP disclosed
US-5021413-A Analgesic thiomorpholins their preparation, and pharmaceutical compositions containing them SANKYO COMPANY LIMITED (JP) 1991-06-04 US disclosed
EP-0356247-A1 Analgesic carboxylic acid amide derivatives Sankyo Company Limited (JP) 1990-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10793584-B2 Naphthobischalcogenadiazole derivative and production method therefor CYP24A1, CYP26B1, CYP21A2 ALDH1A1 600/4885HSD17B10 947/4885CYP2A6 96/4885
US-20190337966-A1 NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR CYP24A1, CYP26B1, CYP21A2 ALDH1A1 600/4885HSD17B10 947/4885CYP2A6 96/4885
US-20230114799-A1 ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER IDH3A, IDH2, IDH3B ALDH1A1 666/4885HSD17B10 331/4885CYP2A6 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.